Noven Pharmaceuticals Inc: Drug Recall
Recall #D-0470-2023 · 03/10/2023
Class II: Risk
Recall Details
- Recall Number
- D-0470-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Noven Pharmaceuticals Inc
- Status
- Ongoing
- Date Initiated
- 03/10/2023
- Location
- Miami, FL, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- N/A
Reason for Recall
Defective Delivery System: Out of specification for shear.
Product Description
Daytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5552-3.
Distribution Pattern
US Nationwide
Other Recalls by Noven Pharmaceuticals Inc
- Class II: Risk 10/31/2024
- Class II: Risk 03/10/2023
- Class II: Risk 03/10/2023
- Class II: Risk 03/10/2023
- Class II: Risk 11/16/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.